US biotech firm Moderna on Wednesday announced initial data from a small clinical trial that showed its booster shots improved people’s immune responses against key coronavirus variants of concern.
US biotech firm Moderna on Wednesday announced initial data from a small clinical trial that showed its booster shots improved people’s immune responses against key coronavirus variants of concern.
